Stock CHRS COHERUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq
Other stock markets
 21:00:00 24/05/2024 BST 		5-day change 1st Jan Change
1.91 USD -4.98% Intraday chart for Coherus BioSciences, Inc. -9.91% -42.64%
05-23 Coherus Biosciences, Inc. Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-Chemokine Receptor 8 Antibody, CHS-114, at the 2024 American Society of Clinical Oncology Annual Meeting CI
05-13 Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
COHERUS BIOSCIENCES, INC.
Bio Therapeutic Drugs
-4.98%-9.91%-42.64%-56.09%-90.62% 219M
Neutral
Bearish
Neutral
  1. Stock Market
  2. Equities
  3. CHRS Stock
  4. Charts Coherus BioSciences, Inc.
  5. Relative Strength Chart